Breaking News Instant updates and real-time market news.

NOVN

Novan

$23.79

0.5 (2.15%)

06:07
11/29/16
11/29
06:07
11/29/16
06:07

Novan announces 'statistically significant' Phase 2 results for SB206

Novan announced top-line results from the company's Phase 2 clinical trial with SB206 for the treatment of genital warts caused by human papillomavirus, or HPV. The highest dose tested, SB206 12%, demonstrated a statistically significant improvement (pless than0.05) in the incidence of complete clearance of all baseline warts compared to vehicle treatment after 12 weeks in both the intent-to-treat and per-protocol analyses. Based on the data generated in this Phase 2 dose-ranging trial, Novan expects to discuss the entirety of the SB206 development program with the U.S. Food and Drug Administration, or FDA, in the first half of 2017 and, assuming a successful end-of-Phase 2 meeting with the FDA, plans to initiate the Company's late-stage program with Phase 3 pivotal clinical trials of SB206 in the second half of 2017.

  • 29

    Nov

NOVN Novan
$23.79

0.5 (2.15%)

10/17/16
PIPR
10/17/16
INITIATION
Target $25
PIPR
Overweight
Novan initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst David Amsellem started Novan with an Overweight rating and $25 price target. The analyst believes the company's Nitricil platform in medical dermatology has the potential to "drive transformative longer-term value creation."
10/17/16
WEDB
10/17/16
INITIATION
Target $27
WEDB
Outperform
Novan initiated with an Outperform at Wedbush
Wedbush analyst David Nierengarten initiated Novan with an Outperform and a $27price target saying the company is expected to experience major near-term catalysts, including Ph 3 readout of SB204 in acne in 1Q17 and Ph 2 SB206 data in genital warts by YE16. The analyst expects SB204's differentiated profile to result in a first pass approval in late 2018 and launch soon after and SB206 data to support further development.
10/17/16
JMPS
10/17/16
INITIATION
JMPS
Outperform
Novan initiated with an Outperform at JMP Securities
Analyst Donald Ellis started Novan with an Outperform rating and a $31 price target.
10/17/16
10/17/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Freeport McMoRan (FCX) reinstated with an Underperform at BofA/Merrill. 2. Novan (NOV) initiated with an Overweight at Piper Jaffray, an Outperform at Wedbush, and an Outperform at JMP Securities. 3. CapStar Financial (CSTR) initiated with a Market Perform at Keefe Bruyette, a Hold at Sandler O'Neill, and an Outperform at Raymond James. 4. Trade Desk (TTD) initiated with a Buy at Jefferies, an Outperform at RBC Capital, a Buy at Citi, a Buy at Needham, and an Outperform at Raymond James. 5. e.l.f. Beauty (ELF) initiated with a Neutral at JPMorgan, an Overweight at Piper Jaffray, a Market Perform at Wells Fargo, an Outperform at William Blair, a Hold at Stifel, a Buy at SunTrust, an Outperform at Cowen, and an Equal Weight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

10:50
02/27/17
02/27
10:50
02/27/17
10:50
General news
U.S. Dallas Fed manufacturing index rose 2.4 points to 24.5 in February »

U.S. Dallas Fed…

HBI

Hanesbrands

$20.60

-0.78 (-3.65%)

10:47
02/27/17
02/27
10:47
02/27/17
10:47
Technical Analysis
Hanesbrands drops, levels to watch »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

10:45
02/27/17
02/27
10:45
02/27/17
10:45
General news
Treasury Action: already elevated yields inched up further »

Treasury Action: already…

10:45
02/27/17
02/27
10:45
02/27/17
10:45
General news
Breaking General news story  »

Dallas Federal Reserve…

SPKE

Spark Energy

$27.25

1.7 (6.65%)

10:44
02/27/17
02/27
10:44
02/27/17
10:44
Recommendations
Spark Energy analyst commentary  »

Janney says Spark Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

10:44
02/27/17
02/27
10:44
02/27/17
10:44
General news
Dallas Fed Mfg Survey Production Index data reported »

February Dallas Fed Mfg…

UPS

UPS

$105.88

-0.3 (-0.28%)

10:41
02/27/17
02/27
10:41
02/27/17
10:41
Options
Opening action in UPS downside puts »

Opening action in UPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

10:37
02/27/17
02/27
10:37
02/27/17
10:37
General news
Dallas Fed Mfg Survey Production Index data reported »

February Dallas Fed Mfg…

TVPT

Travelport

$12.88

-0.06 (-0.46%)

10:33
02/27/17
02/27
10:33
02/27/17
10:33
Conference/Events
Travelport management to meet with Evercore ISI »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

PGNX

Progenics

$10.36

0.12 (1.17%)

10:32
02/27/17
02/27
10:32
02/27/17
10:32
Conference/Events
Progenics management to meet with Aegis »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 09

    Mar

ORIT

Oritani Financial

$17.15

-0.05 (-0.29%)

10:31
02/27/17
02/27
10:31
02/27/17
10:31
Conference/Events
Oritani Financial management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 02

    Mar

  • 15

    May

X

U.S. Steel

$37.37

0.355 (0.96%)

10:31
02/27/17
02/27
10:31
02/27/17
10:31
Options
Bullish short-term option play in US Steel as shares see strength »

Bullish short-term option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIP

VimpelCom

$4.30

-0.04 (-0.92%)

10:30
02/27/17
02/27
10:30
02/27/17
10:30
Earnings
VimpelCom reports Q4 EBITDA $783M »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMS

Maximus

$60.41

0.1049 (0.17%)

10:30
02/27/17
02/27
10:30
02/27/17
10:30
Conference/Events
Maximus management to meet with Maxim »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 01

    Mar

  • 02

    Mar

10:29
02/27/17
02/27
10:29
02/27/17
10:29
General news
Market little changed in early trading as investors await Trump address »

Stock futures drifted…

CTSO

CytoSorbents

$5.60

0.05 (0.90%)

10:28
02/27/17
02/27
10:28
02/27/17
10:28
Conference/Events
CytoSorbents management to meet with B. Riley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 03

    Mar

VIP

VimpelCom

$4.30

-0.04 (-0.92%)

10:27
02/27/17
02/27
10:27
02/27/17
10:27
Hot Stocks
VimpelCom introduces new dividend policy »

VimpelCom introduces a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CL

Colgate-Palmolive

$72.93

-0.42 (-0.57%)

10:26
02/27/17
02/27
10:26
02/27/17
10:26
Options
Colgate Palmolive call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$33.77

0.265 (0.79%)

10:25
02/27/17
02/27
10:25
02/27/17
10:25
Conference/Events
BP management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 06

    Mar

10:25
02/27/17
02/27
10:25
02/27/17
10:25
General news
Treasury Action: yields remained above lows »

Treasury Action: yields…

BAH

Booz Allen

$36.13

0.205 (0.57%)

10:24
02/27/17
02/27
10:24
02/27/17
10:24
Conference/Events
Booz Allen management to meet with Drexel Hamilton »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

VCYT

Veracyte

$7.95

0.06 (0.76%)

10:23
02/27/17
02/27
10:23
02/27/17
10:23
Hot Stocks
Veracyte: Data show potential for non-invasive test to improve cancer diagnosis »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

AXP

American Express

$79.75

-0.01 (-0.01%)

, GOOG

Alphabet

$828.64

-2.69 (-0.32%)

10:23
02/27/17
02/27
10:23
02/27/17
10:23
Hot Stocks
American Express says doesn't have a 'deep' partnership with Google right now »

Says Marriott (MAR) has…

AXP

American Express

$79.75

-0.01 (-0.01%)

GOOG

Alphabet

$828.64

-2.69 (-0.32%)

MAR

Marriott

$87.08

0.08 (0.09%)

HOT

Starwood

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 06

    Mar

  • 19

    Mar

AAN

Aaron's

$27.23

0.05 (0.18%)

10:22
02/27/17
02/27
10:22
02/27/17
10:22
Conference/Events
Aaron's management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

10:20
02/27/17
02/27
10:20
02/27/17
10:20
General news
FX Action: USD-CAD »

FX Action: USD-CAD traded…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.